Skip to content

NanoCross™ Elite AB14W030150150 (UDI 00763000109868)Recalls & reported problems

Ev3, Inc · PTA AB14W030150150 NANOCROSS 014 V05 · Class 2

All models of NanoCross Elite (63)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00763000109868), received between Apr 9, 2020 and Feb 13, 2024 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (3 reports).

1 other recall cover devices cleared under the same FDA submission (K141118); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Detachment of Device or Device Component3
  • Difficult to Advance1
  • Difficult to Remove1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 13, 2024Difficult to Remove; Detachment of Device or Device Component; Difficult to Remove; Detachment of Device or Device Component

    PHYSICIAN ATTEMPTED TO USE A NANOCROSS ELITE PTA BALLOON DURING TREATMENT OF A PLAQUE LESION IN THE PATIENTS PROXIMAL MID DISTAL SUP ERFICIAL FEMORAL ARTERY (SFA). LITTLE VESSEL TORTUOSITY AND LITTLE VESSEL CALCIFICATION WERE REPORTED. LESION EXHIBITED 70% STENOSIS. THERE WERE NO ABNORMALITIES REPORTED IN RELATION TO ANATOMY. EMBOLIC PROTECTION WAS NOT USED. AN INFLATION DEVICE WAS USED FOR BAL LOON INFLATION. THERE WAS NO DAMAGE NOTED TO PACKAGING, I.E. SHELF CARTON, HOOP, TRAY. NO ISSUES WERE NOTED WHEN REMOVING THE DEVICE FROM THE HOOP, TRAY. THE IFU WAS FOLLOWED AND THE DEVICE WAS PREPPED WITHOUT ISSUE. NO RESISTANCE WAS NOTED DURING ADVANCEMENT OF THE DEVICE. EXCESSIVE FORCE WAS NOT USED. THE DEVICE WAS PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. IT WAS REPORTED THE BALLOON DETACHED FROM CATHETER WHEN PULLING PTA OUT POST INFLATION. DIFFICULTY REMOVING BALLOON FOLLOWING BALLOON INFLATION WAS ALSO REPORTED. THE DETACHED PORTION OF DEVICE DOES NOT REMAIN IN PATIENT. DEVICE WAS PULLED OUT AND PHYSICIAN REWIRED WITH NEW WIRE TO COMPLETE PROCEDURE. NO PATIENT INJURY REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18695066 ↗
  • InjuryMay 11, 2023Detachment of Device or Device Component; Difficult to Advance; Detachment of Device or Device Component; Difficult to Advance

    A PHYSICIAN WAS USING A NANOCROSS PTA BALLOON FOR TREATMENT OF A CALCIFIED LESION WITH 90% STENOSIS IN THE PROXIMAL REGION OF THE SU PERFICIAL FEMORAL ARTERY. THERE WAS MILD TORTUOSITY AND SEVERE CALCIFICATION. A 6FR SHEATH AND A NON MEDTRONIC GUIDEWIRE WERE USED. EMBOLIC PROTECTION WAS NOT USED. A NON-MEDTRONIC INFLATION DEVICE WAS USED. THE DEVICE WAS PREPPED AS PER THE IFU WITH NO ISSUES IDENTIFIED. IT WAS REPORTED THE PATIENT HAD A CUTDOWN WITH ANTEGRADE ACCESS, AFTER INFLATION OF BALLOON, BALLOON WAS DEFLATED AND BEGAN TO BE REMOVED. HEARD A LOUD CRACK AND IT WAS NOTICED THE BALLOON HAD BROKEN AWAY FROM THE CATHETER. PATIENT HAD A CUTDOWN ALREADY FOR AN ENDART. DETACHMENT OCCURRED UPON WITHDRAWAL INTO SHEATH, REMOVED SHEATH AND BALLOON CATHETER. BITS OF THE BALLOON REMAINED ON THE WIRE. USED FORCEPS TO REMOVE BITS FROM WIRE. EXCHANGED WIRE AND CONTINUED PROCEDURE. THE DEVICE HAD PASSED THROUGH A PREVIOUSLY DEPLOYED STENT AND RESISTANCE WAS ENCOUNTERED DURING ADVANCEMENT. NO FURTHER PATIENT INJURY REPORTED FOR THIS EVENT

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16911243 ↗
  • MalfunctionApr 9, 2020Detachment of Device or Device Component; Detachment of Device or Device Component

    IT WAS REPORTED THAT DURING PROCEDURE USING NANOCROSS PTA BALLOON CATHETER, THE BALLOON PEELED AWAY FROM THE CATHETER WHILE IN THE PATIENT. IT STAYED ATTACHED TO CATHETER SO REMOVED AS NORMAL. NOTHING WAS LEFT BEHIND IN PATIENT. BALLOON WAS INFLATED USING A NON MEDTRONIC INDEFLATOR. DEVICE WAS PREPPED PER IFU WITH NO ISSUES IDENTIFIED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT AND NO EXCESSIVE FORCE USED WHILE ADVANCING THE DEVICE. PROCEDURE WAS COMPLETED AS NORMAL. THERE WAS NO PATIENT INJURY REPORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9943734 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K141118. One submission often covers many models, so check the product and lot details in each record.

  • Z-0904-2025 · Dec 10, 2024 · Open, Classified
    Medtronic NanoCross Elite PTA catheter, REF numbers amd sizes: 1) AB14W050020090, Size: 5MM X 20MM X 90CM; 2) AB14W050020150, Size: 5MM X 20MM X 150CM; 3) AB14W050040090,

Other Catheter, percutaneous devices

All Catheter, percutaneous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page